• Mutation; HGNC; HGNC:427; ALK; Simple; p.Lys1491Arg (c.4472A>G); ClinVar=VCV000133474; Zygosity=Unspecified (PubMed=30991738).
  
• Mutation; HGNC; HGNC:7773; NF2; Simple; p.Asp213fs (c.639delC); Zygosity=Unspecified (PubMed=30991738).
  
• Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Pro1164Leu (c.3944C>T); ClinVar=VCV000041663; Zygosity=Unspecified (PubMed=30991738).
  

PubMed=30991738; DOI=10.3390/cancers11040545; PMCID=PMC6521001
Gerhard Jungwirth, Tao Yu, Mahmoud Moustafa, Carmen Rapp, Rolf Warta, Christine Jungk, Felix Sahm, Steffen Dettling, Klaus Zweckberger, Katrin Lamszus, Christian Senft ...Show all 21 authors... , Mario Lohr, Almuth Friederike Kessler, Ralf Ketter, Manfred Westphal, Juergen Debus, Andreas von Deimling, Matthias Simon, Andreas Unterberg, Amir Abdollahi, Christel Herold-Mende; Show fewer authors
Identification of KIF11 as a novel target in meningioma.
Cancers (Basel) 11:545.1-545.18(2019)

PubMed=34885009; DOI=10.3390/cancers13235898; PMCID=PMC8657092
Tao Yu, Jun-Guo Cao, Montadar Alaa Eddine, Mahmoud Moustafa, Andreas Mock, Cihan Erkut, Amir Abdollahi, Rolf Warta, Andreas Unterberg, Christel Herold-Mende, Gerhard Jungwirth;
Receptor-tyrosine kinase inhibitor ponatinib inhibits meningioma growth in vitro and in vivo.
Cancers (Basel) 13:5898.1-5898.16(2021)